Cita APA

Lin, S., Lu, S., Chen, P., Jeng, L., Chen, S., Hu, C., . . . Meinhardt, G. (2016). HATT: A phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma. Hepatol Int.

Citación estilo Chicago

Lin, Shi-Ming, et al. "HATT: A Phase IV, Single-arm, Open-label Study of Sorafenib in Taiwanese Patients With Advanced Hepatocellular Carcinoma." Hepatol Int 2016.

Cita MLA

Lin, Shi-Ming, et al. "HATT: A Phase IV, Single-arm, Open-label Study of Sorafenib in Taiwanese Patients With Advanced Hepatocellular Carcinoma." Hepatol Int 2016.